{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:20:33Z","timestamp":1791822033708,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012781","name":"MSD K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jiac.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T02:55:59Z","timestamp":1541213759000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: A hospital claims database study"],"prefix":"10.1016","volume":"25","author":[{"given":"Daniel J.","family":"Ruzicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-9930","authenticated-orcid":false,"given":"Toshio","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.10.006_bib1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/COH.0000000000000076","article-title":"Demographics of HIV and aging","volume":"9","author":"Costagliola","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jiac.2018.10.006_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/QCO.0b013e32835ba6b1","article-title":"Life expectancy living with HIV: recent estimates and future implications","volume":"26","author":"Nakagawa","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.006_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2018.10.006_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","article-title":"Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care","volume":"73","author":"Marcus","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiac.2018.10.006_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12603-015-0608-7","article-title":"Impact of age-related comorbidities on five-year overall mortality among elderly HIV-infected patients in the late HAART era\u2014role of chronic renal disease","volume":"20","author":"Hentzien","year":"2016","journal-title":"J\u00a0Nutr Health Aging"},{"key":"10.1016\/j.jiac.2018.10.006_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/09540121.2012.712669","article-title":"Chronic illness burden and quality of life in an aging HIV population","volume":"25","author":"Balderson","year":"2013","journal-title":"AIDS Care"},{"key":"10.1016\/j.jiac.2018.10.006_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jana.2010.04.002","article-title":"Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life","volume":"22","author":"Vance","year":"2011","journal-title":"J\u00a0Assoc Nurses AIDS Care"},{"key":"10.1016\/j.jiac.2018.10.006_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2018.10.006_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyh307","article-title":"Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS","volume":"34","author":"Lewden","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2018.10.006_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2010.00859.x","article-title":"HIV and the body: a review of multidisciplinary management","volume":"11","author":"Rockstroh","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.jiac.2018.10.006_bib11","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/jac\/dkr248","article-title":"Ageing with HIV: medication use and risk for potential drug-drug interactions","volume":"66","author":"Marzolini","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.10.006_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cger.2012.01.008","article-title":"Medication adherence to multidrug regimens","volume":"28","author":"Marcum","year":"2012","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jiac.2018.10.006_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2018.10.006_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0009-9236(97)90166-1","article-title":"Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions","volume":"61","author":"Sotaniemi","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jiac.2018.10.006_bib15","doi-asserted-by":"crossref","first-page":"e019985","DOI":"10.1136\/bmjopen-2017-019985","article-title":"Comorbidities and the use of co-medications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database","volume":"8","author":"Ruzicka","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiac.2018.10.006_bib16","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2018.10.006_bib17","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cid\/ciu701","article-title":"Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study","volume":"59","author":"Schouten","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.006_bib18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.006_bib19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1086\/523577","article-title":"Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?","volume":"45","author":"Goulet","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.006_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/hiv.12116","article-title":"Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection","volume":"15","author":"Gedela","year":"2014","journal-title":"HIV Med"},{"key":"10.1016\/j.jiac.2018.10.006_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(13)70271-8","article-title":"Metabolic disease in HIV infection","volume":"13","author":"Lake","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.006_bib22","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992\u20132003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2018.10.006_bib23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A\u00a0meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals","volume":"52","author":"Shiels","year":"2009","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3 Suppl","key":"10.1016\/j.jiac.2018.10.006_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1521\/aeap.2009.21.3_supp.14","article-title":"Review: the need for smoking cessation among HIV-positive smokers","volume":"21","author":"Nahvi","year":"2009","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.jiac.2018.10.006_bib25","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/QAD.0b013e3283319184","article-title":"HIV infection and the risk of cancers with and without a known infectious cause","volume":"23","author":"Silverberg","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2018.10.006_bib26","series-title":"Cancer Information Service, National Cancer Center, Japan. National estimates of cancer incidence based on cancer registries in Japan (1975\u20132014)","author":"Cancer Registry and Statistics","year":"2018"},{"key":"10.1016\/j.jiac.2018.10.006_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2016.10.004","article-title":"HIV and aging","volume":"53","author":"Wing","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.006_bib28","doi-asserted-by":"crossref","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity","volume":"338","author":"Deeks","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2018.10.006_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jiac.2018.10.006_bib30","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/QAD.0000000000001475","article-title":"Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy","volume":"31","author":"Rajasuriar","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2018.10.006_bib31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/1060028013504075","article-title":"Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients","volume":"47","author":"Tseng","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiac.2018.10.006_bib32","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s11606-013-2449-6","article-title":"Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population","volume":"28","author":"Holtzman","year":"2013","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jiac.2018.10.006_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3851\/IMP1540","article-title":"Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV cohort study","volume":"15","author":"Marzolini","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jiac.2018.10.006_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","article-title":"The next therapeutic challenge in HIV: polypharmacy","volume":"30","author":"Edelman","year":"2013","journal-title":"Drugs Aging"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:58Z","timestamp":1761159478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18303982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1341321X18303982"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.10.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: A hospital claims database study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}